Scholars Central

Conference abstractPublished 1 Mar 2018

Considerations for creating a protocol for vedolizumab infusions

Authors: Deepti B Prajapati

New York University Langone Medical Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Vedolizumab (Entyvio Ã?®) is one of the several treatment options for the management of ulcerative colitis and Crohn's disease. It is a recombinant humanized anti-alpha-4-beta-7 integrin monoclonal antibody. This biologic immunotherapy is utilized in patients who have failed or achieved inadequate response to the different therapies currently available for these disease processes. Certain considerations include monitoring for Progressive multifocal leukoencephalopathy (PML) and liver injury. These are rare adverse effects and occurrences. A protocol for the safe administration of vedolizumab at NYU's Infusion Center is based on current prescribing guidelines.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Nursing & Care.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nursing & Care
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Deepti B Prajapati”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels